Asem H. Mansour, MD, has served as CEO and Director General of Jordan’s King Hussein Cancer Center (KHCC), the largest standalone comprehensive cancer center in the Middle East, since 2012. In this role, he leads over 3000 staff members, including 400 oncologists and consultants in executing KHCC’s vision to provide the highest quality care to cancer patients throughout the region.
Dr. Mansour’s affiliation with KHCC dates back to 1998, when he was appointed Chairman of the Department of Diagnostic Radiology, and subsequently led the department to become one of the most advanced diagnostic imaging facilities in the Kingdom, with highly qualified staff and state-of-the-art machinery.
In 2006, Dr. Mansour became KHCC’s Deputy Director General and was promoted in early 2012 to be the Center’s Director General and the Executive Chairman of the Jordan Breast Cancer Program (JBCP), a national program concerned with activating early detection of breast cancer by improving the quality of services provided across Jordan.
A renowned certified Diagnostic Radiologist with a subspecialty fellowship in Neuroradiology (ESNR), Dr. Mansour earned his M.D. from the Vitebsk Medical Institute, School of Medicine. He successfully pursued a fellowship through the Royal College of Radiologists (FRCR- London) and also holds a Master degree of Medical Management (MMM) from the Carnegie Mellon University, USA.
Dr. Mansour is an accomplished, published author of the famous debut book “Two Years of Solitude”, published September of 2021, in which discussed the most important controversial issues that we faced during the pandemic, and stressed the importance of our reliance on scientific sources to obtain information that help confront the massive global health crisis and the significant psychological burdens it places on individuals, in an effective and safe manner.
He is also an editor, a columnist, an active reviewer, who co-authored in over 60 peer-reviewed publications and prestigious medical journals. In 2022, he coauthored an eBook published in Frontiers Journals entitled “Bioethics amidst the COVID-19 Pandemic”.